Stronger Flu Vaccine Approved for U.S. Seniors

Do you read any international newspapers? It’s often worth doing, just because of the news coverage you’ll find which for whatever reason doesn’t make the grade in U.S. publications. For instance, The Hong Kong Standard picked up this story from the AP wire: Fluad, a stronger seasonal flu vaccine, which was first approved internationally in 1997, and has long been available in Europe and Canada, was finally approved by the FDA for U.S. seniors, aged 65 and older. Ask your doctor.